Kumiko Kishimoto

European Treatment and Outcome Study score does not predict imatinib treatment response and outcome in chronic myeloid leukemia patients

Eri Yamamoto, Shin Fujisawa, Maki Hagihara et al. · Cancer Science · 2013 · 39 citations · Full text

Medicine, Hematology, Oncology +14

R‐<scp>CHOP</scp> therapy alone in limited stage diffuse large B‐cell lymphoma

Naoto Tomita, Hirotaka Takasaki, Kazuho Miyashita et al. · British Journal of Haematology · 2013 · 25 citations · Full text

Medicine, Hematology, Oncology +15

Intrathecal methotrexate prophylaxis and central nervous system relapse in patients with diffuse large B-cell lymphoma following rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone

Naoto Tomita, Hirotaka Takasaki, Yasufumi Ishiyama et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2014 · 25 citations

Medicine, Oncology, Pharmacology +15

Absolute monocyte count in follicular lymphoma patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone

Reina Watanabe, Naoto Tomita, Kumiko Kishimoto et al. · Leukemia Research · 2013 · 19 citations

Medicine, Hematology, Oncology +13

Standard R-CHOP Therapy in Follicular Lymphoma and Diffuse Large B-Cell Lymphoma

Naoto Tomita, Hirotaka Takasaki, Shin Fujisawa et al. · Journal of Clinical and Experimental Hematopathology · 2013 · 16 citations · Full text

Medicine, Hematology, Oncology +11